Skip to content

Efficacy of Abhijitha Taila Nasya vs Drusthivardhana Taila Nasya with Tila Taila Padaabhyanga in Simple Myopia

A Randomized Comparative Clinical Study to evaluate Efficacy of Abhijitha Taila Nasya and Drusthivardhana Taila Nasya Along with Tila Taila Padaabhyanga in the management of Prathama patalgahta Timira With special Reference to Simple Myopia. - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/08/092954
Enrollment
40
Registered
2025-08-12
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H538- Other visual disturbances

Interventions

None listed

Sponsors

RGUHS Bangalore
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. The patient presenting with features of Prathama Patalagatha Timira were selected with irrespective of sex occupation religion 2. Those who are fit for Nasya 3. Patient having age between 8 - 25 years 4. Patient having -0.25D to -5D of vision

Exclusion criteria

Exclusion criteria: 1. Dwithiya, Thruthiya, Chatura Patalagatha Timira 2. High Myopia or Progressive Myopia 3. Congenital Myopia 4. Hypermetropia and Presbyopia 5. Those are having more than -5D of vision 6. Myopia with systemic disease like T.B, Hypertensive, DM

Design outcomes

Primary

MeasureTime frame
Change in distant Vision (snellens chart reading) score Subjective Symptom Relief Score (eye strain, headache, watering, blurred vision assessed via a standardized questionnaire) Patient Global Assessment of Improvement (5-point Likert scale) Timepoint: End of treatment (Day 30) and follow-up (Day 60)

Secondary

MeasureTime frame
Change in distant Vision (snellens chart reading) score Subjective Symptom Relief Score (eye strain, headache, watering, blurred vision assessed via a standardized questionnaire) Patient Global Assessment of Improvement (5-point Likert scale) Timepoint: End of treatment (Day 30) & follow-up (Day 60)

Countries

India

Contacts

Public ContactDrVidyashree Hiremath

BVVS Ayurveda Medical College and Hospital, Bagalkot

vidyashri30@gmail.com8904240364

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026